European Seventh Framework Programme
- University of Freiburg
METOXIA is a large-scale Collaborative Project of the seventh framework programme within the theme HEALTH financed by the European Commission. The total budget is 15.8 million euros while the EC-contribution is close to 12 million euros. There are 22 partners from 11 different countries in Europe and the co-ordinating university is UiO (Department of Physics). The project runs for 5 years and started the 1st February 2009.
Being a cancer research project METOXIA focuses on so-called translational research. This means that knowledge is to be translated from fundamental research to clinical practice. The project involves research within a broad range of fields: Engineering (electronics and chemical sensing), pre-clinical molecular biology and radiobiology (in a wide range of biological models) and clinical testing in patients.
The scientific common denominator is the mechanisms activated by lack of oxygen in cancer tumours, leading to treatment resistance of the cancer as well as to the malignant selection taking place in the patient ending up in the fatal process of metastasis. The project involves development of new drugs, new radiation strategies, new micro-environmental sensors as well as biomarkers for patient diagnosis and stratification.